Royal Stoke University Hospital
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-Market Clinical Follow Up Study With Navitor Valve | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not stated | 2026-07-10 | NCT06008080 | |
| Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-04-30 | NCT04546620 | |
| Closed-loop for People Living With Cystic Fibrosis Related Diabetes | cystic fibrosis-related diabetes | Active, not recruiting | Not applicable | 2026-02-20 | NCT05562492 | |
| PreOperative Endocrine Therapy for Individualised Care With Abemaciclib | Breast Cancer Female | Active, not recruiting | Phase 3 | 2026-01-14 | NCT04584853 | |
| Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer | estrogen-receptor positive breast cancer | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-26 | NCT01992952 | |
| POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2025-07-10 | NCT02401685 | |
| Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism, Embolism and Thrombosis, Hemorrhage, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, Venous Thrombosis, atrial septal defect, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, intracranial thrombosis, ischemic disease, ischemic stroke, lung disorder, myocardial infarction, myocardial ischemia, nervous system disorder, patent foramen ovale, pulmonary embolism, respiratory system disorder, stroke disorder, subarachnoid hemorrhage, thrombotic disease, vascular disorder | Active, not recruiting | Not stated | 2025-05-16 | NCT01934725 | |
| Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Phase 3 | 2024-12-05 | NCT01566240 | |
| Prostate Advances in Comparative Evidence | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2024-01-19 | NCT01584258 | |
| The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2018-06-19 | NCT03562169 |